Verdiva Bio has completed enrolment for its phase 2b EVOLVE‑2 clinical study of VRB‑101, a once‑weekly oral GLP‑1 peptide analog being developed for body‑weight reduction in people with overweight or ...
The Medicines and Healthcare products Regulatory Agency has approved imlunestrant tosylate, branded as Inluriyo, for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results